Advancing Innovative Biomedical Research
The institute provides a world-class interdisciplinary training environment for the preparation of technically skilled students who are capable of filling the diverse workforce needs in biomedical sciences. With key assets including centers for the study of inflammation, immunity and infection, microbial pathogenesis, oncology, molecular and cellular medicine and diagnostics and therapeutics the unit delivers both academic and research value to the field.
Breakthroughs in Georgia: Enterprising Biomedicine
In a very short time, Georgia State University has built an impressive research enterprise. It’s the Institute of Biomedical Sciences, and its scientists are unlocking new insights and answers to an array of diseases and ailments. Tens of millions of dollars in research grants flow into the Institute each year, and the university is planning even more expansion.
Institute News
Researcher Gets $3.86 Million Grant To Develop Universal Flu Vaccine With Microneedle Patch
ATLANTA—Dr. Baozhong Wang, associate professor in Georgia State University’s Institute for Biomedical Sciences, has received a five-year, $3.86 million federal grant to develop a universal flu vaccine using a microneedle patch that will protect against any strain of the influenza virus.
Researcher Gets $552,000 Grant to Study How Dietary Fiber Can Protect Against Diabetes
ATLANTA—Dr. Jun Zou, a research assistant professor in the Institute for Biomedical Sciences at Georgia State University, has received a four-year, $552,000 grant to study how dietary fiber can protect against diabetes and other disorders associated with metabolic syndrome.
Ebola-Fighting Molecule Found In Human Cells
Viruses tend to travel light. They carry around a small cargo of proteins and minimal genetic instructions, and instead use the unwitting host’s cells to do the hard work of making more virus.
“Viruses are parasites that rely on the cell they infect to reproduce,” says Dr. Christopher Basler of Georgia State University, who is particularly interested in how the Ebola virus does this.
Vaccine Using Microneedle Patch With RSV Virus, Immune-Stimulating Compound Is Effective Against RSV
ATLANTA—Skin vaccination using a microneedle patch that contains the inactivated respiratory syncytial virus (RSV) and a compound that stimulates immune responses to the virus has been found to enhance protection against this serious disease and reduce inflammation in the body after exposure to the virus, according to a study led by Georgia State University.
Contact Us
Phone: 404-413-3578
Fax: 404-413-3580
Email: biomedical@gsu.edu
Mailing Address:
P.O. Box 5035
Atlanta, GA
30303-5035